Page last updated: 2024-11-01

niclosamide and Eczema, Atopic

niclosamide has been researched along with Eczema, Atopic in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Weiss, A1
Delavenne, E1
Matias, C1
Lagler, H1
Simon, D1
Li, P1
Hansen, JU1
Dos Santos, TP1
Jana, B1
Priemel, P1
Bangert, C1
Bauer, M1
Eberl, S1
Nussbaumer-Pröll, A1
Anne Österreicher, Z1
Matzneller, P1
Quint, T1
Weber, M1
Nielsen, HM1
Rades, T1
Johansen, HK1
Westh, H1
Kim, W1
Mylonakis, E1
Friis, C1
Guardabassi, L1
Pace, J1
Lundberg, CV1
M'Zali, F1
Butty, P1
Sørensen, N1
Nielsen, HB1
Toft-Kehler, R1
Guttman-Yassky, E1
Stingl, G1
Zeitlinger, M1
Sommer, M1

Trials

1 trial available for niclosamide and Eczema, Atopic

ArticleYear
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.
    Clinical and translational medicine, 2022, Volume: 12, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Dermatitis, Atopic; Humans; Methicillin-Resistant Staphylococcus aur

2022